These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1360405)

  • 1. Kindled rats are more sensitive than non-kindled rats to the behavioural effects of combined treatment with MK-801 and valproate.
    Dziki M; Hönack D; Löscher W
    Eur J Pharmacol; 1992 Nov; 222(2-3):273-8. PubMed ID: 1360405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats.
    Löscher W; Hönack D
    Eur J Pharmacol; 1993 Apr; 234(2-3):237-45. PubMed ID: 8097722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
    Wlaź P; Ebert U; Potschka H; Löscher W
    Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy.
    Löscher W; Rundfeldt C; Hönack D
    Eur J Neurosci; 1993 Nov; 5(11):1545-50. PubMed ID: 7904524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systemic administration.
    Cotterell KL; Croucher MJ; Bradford HF
    Eur J Pharmacol; 1992 Apr; 214(2-3):285-7. PubMed ID: 1355438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in anticonvulsant potency and adverse effects between dextromethorphan and dextrorphan in amygdala-kindled and non-kindled rats.
    Löscher W; Hönack D
    Eur J Pharmacol; 1993 Jul; 238(2-3):191-200. PubMed ID: 8405092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
    Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
    Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME
    Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats.
    Wlaź P; Ebert U; Löscher W
    Neuropharmacology; 1999 Feb; 38(2):243-51. PubMed ID: 10218865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats.
    Hönack D; Rundfeldt C; Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):187-96. PubMed ID: 1570023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice.
    Czechowska G; Dziki M; Pietrasiewicz T; Kleinrok Z; Turski WA; Czuczwar SJ
    Eur J Pharmacol; 1993 Feb; 232(1):59-64. PubMed ID: 8096188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new competitive NMDA receptor antagonist CGP 40116 inhibits pilocarpine-induced limbic motor seizures and unconditioned motor behaviour in the mouse.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1994 Jan; 47(1):127-31. PubMed ID: 7906888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NMDA receptor antagonist MK-801 has a dissociative effect on seizure activity of hippocampal-kindled cats.
    Wada Y; Hasegawa H; Nakamura M; Yamaguchi N
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1269-72. PubMed ID: 1475311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate receptor antagonists differentially affect the protective activity of conventional antiepileptics against amygdala-kindled seizures in rats.
    Borowicz KK; Kleinrok Z; Czuczwar SJ
    Eur Neuropsychopharmacol; 2001 Feb; 11(1):61-8. PubMed ID: 11226813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of CHF3381 as a novel antiepileptic agent.
    Villetti G; Bregola G; Bassani F; Bergamaschi M; Rondelli I; Pietra C; Simonato M
    Neuropharmacology; 2001 Jun; 40(7):866-78. PubMed ID: 11378157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.
    Dürmüller N; Craggs M; Meldrum BS
    Epilepsy Res; 1994 Feb; 17(2):167-74. PubMed ID: 8194512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate prevents the induction and the expression of MK-801 sensitization.
    Yang PB; Swann AC; Dafny N
    Brain Res; 2002 Nov; 954(2):151-9. PubMed ID: 12414098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.